Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Latigo Biotherapeutics

Clinical trials sponsored by Latigo Biotherapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug LTG-001 enters first human safety tests Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 4

New drug LTG-001 enters first human safety tests

Knowledge-focused Ongoing

This early-stage study is testing a new drug, LTG-001, in 204 healthy adults aged 18 to 55. The goal is to check how safe the drug is, how well people tolerate it, and how it moves through the body. Participants will receive either the drug or a placebo by mouth or through a vein…

Phase 1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused

Last updated Jun 27, 2026 14:00 UTC